Ignite Creation Date:
2024-05-06 @ 2:10 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01987011
Status:
COMPLETED
Last Update Posted:
2015-07-03
First Post:
2013-07-22
Brief Title:
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-22
First Submit QC Date:
November 12 2013
Study First Post Date:
2013-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-01
Last Update Post Date:
2015-07-03
Last Update Post Date Type:
ESTIMATED